Top

Published in:

01-06-2020 | Melanoma | Clinical study

Systematic review: melanoma with biologics in inflammatory diseases

Published in: Reactions Weekly | Issue 1/2020

Excerpt

In patients with common immune-mediated inflammatory diseases, clinically important increases in the melanoma risk associated with biologics treatment "cannot be ruled out", according to the results of a systematic review and meta-analysis reported in JAMA Dermatology. …

Esse S, et al. Melanoma Risk in Patients Treated With Biologic Therapy for Common Inflammatory Diseases. A Systematic Review and Meta-analysis. JAMA Dermatology : 20 May 2020. Available from: URL: /link?doi=10.1001/jamadermatol.2020.1300

Title: Systematic review: melanoma with biologics in inflammatory diseases
Publication date: 01-06-2020
Publisher: Springer International Publishing
Keywords: Melanoma
Chronic Inflammatory Bowel Disease
Melanoma
Systemic Therapy
Abatacept
Vulgar Psoriasis
Rheumatoid Arthritis
Published in: Reactions Weekly / Issue 1/2020
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-020-79298-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Systematic review: melanoma with biologics in inflammatory diseases

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2020

Sotalol

Dabigatran-etexilate

Antineoplastics

Multiple drugs

Cetuximab

Triamcinolone